Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

• Autors principals: Martínez del Prado P (Autor), Alvarez-López I (Autor), Domínguez-Fernández S (Autor), Plazaola A (Autor), Ibarrondo O (Autor), Galve-Calvo E (Autor), Ancizar-Lizarraga N (Autor), Gutierrez-Toribio M (Autor), Lahuerta-Martínez A (Autor), Mar J (Autor)
• Format: Llibre
• Publicat: Dove Medical Press, 2018-03-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Purificación Martínez del Prado,1 Isabel Alvarez-López,2,3 Severina Domínguez-Fernández,4 Arrate Plazaola,5 Oliver Ibarrondo,6 Elena Galve-Calvo,1 Nerea Ancizar-Lizarraga,2,3 María Gutierrez-Toribio,4 Ainhara Lahuerta-Martínez,5 Javier Mar6,7 1Medical Oncology Service, Basurto University Hospital, B...